GANYMED Pharmaceuticals
Latest round
- Series E
Last raised
- Nov 2013
Total raised
- $129M
Investors
- 13
About GANYMED Pharmaceuticals
GANYMED Pharmaceuticals AG, founded in 2001 in Mainz, Germany, specializes in pharmaceutical development. The company has undergone no major strategic pivots or changes in business operations and has not reported any subsidiaries. Christoph Huber, the founder of GANYMED, has been instrumental in its establishment. The company has completed a total of 9 deals, with its most recent deal on October 28, 2016, involving a TRADE SALE to Astellas Pharma Inc.GANYMED Pharmaceuticals focuses on developing a range of pharmaceuticals, including tablets, capsules, injections, creams, and syrups, aimed at treating a variety of health issues.Following the TRADE SALE in October 2016 to Astellas Pharma, GANYMED Pharmaceuticals is poised for growth by focusing on the development of new pharmaceutical products and expanding into new geographic markets.
Who invested in GANYMED Pharmaceuticals
13 investors across 4 rounds
See all investors in GANYMED Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GANYMED Pharmaceuticals
Who invested in GANYMED Pharmaceuticals?
GANYMED Pharmaceuticals has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GANYMED Pharmaceuticals raised?
GANYMED Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did GANYMED Pharmaceuticals last raise money?
GANYMED Pharmaceuticals's most recent round on record is a Series E, in Nov 2013.
What does GANYMED Pharmaceuticals do?
GANYMED Pharmaceuticals AG, founded in 2001 in Mainz, Germany, specializes in pharmaceutical development.
Where is GANYMED Pharmaceuticals headquartered?
GANYMED Pharmaceuticals is headquartered in Mainz, Germany.
Which VCs invest in companies like GANYMED Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at GANYMED Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like GANYMED Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.